Soru

Zorluk: ZorSchizophrenia and Psychotic Disorders

A quality improvement committee in a community mental health clinic is reviewing the longitudinal care of a 34-year-old man with a 10-year history of schizophrenia. His clinical course was initially complicated by frequent relapses due to medication nonadherence, and later by severe, persistent auditory hallucinations despite continuous, verified medication delivery. The committee is evaluating whether the sequence of psychopharmacological interventions followed current consensus guidelines for the stepwise management of schizophrenia and treatment-refractory psychosis. Assuming the clinical team followed standard evidence-based algorithms at each stage of his illness, arrange the following interventions in the correct chronological sequence from earliest to latest.

  1. 1Prescribe an oral second-generation antipsychotic as initial monotherapy for the first episode of psychosis.
  2. 2Transition to a long-acting injectable (LAI) antipsychotic to guarantee medication delivery following a relapse due to nonadherence.
  3. 3Initiate clozapine therapy with absolute neutrophil count (ANC) monitoring after diagnosing treatment-resistant schizophrenia.
  4. 4Check a clozapine serum level to rule out pharmacokinetic failure when standard doses yield an inadequate clinical response.
  5. 5Augment the regimen with electroconvulsive therapy (ECT) to treat definitively clozapine-refractory schizophrenia.

Cevap

The correct chronological sequence is: 1) Prescribe an oral second-generation antipsychotic, 2) Transition to a long-acting injectable (LAI), 3) Initiate clozapine therapy, 4) Check a clozapine serum level, 5) Augment the regimen with electroconvulsive therapy (ECT).
The evidence-based treatment algorithm for schizophrenia progresses linearly through specific clinical stages. It begins with an oral second-generation antipsychotic for the first episode. If relapses occur due to nonadherence, a long-acting injectable (LAI) is utilized to guarantee delivery. If symptoms persist despite assured delivery of at least two different trials, treatment-resistant schizophrenia is diagnosed, indicating a switch to clozapine. If standard clozapine dosing is ineffective, a serum level must be evaluated to rule out rapid metabolism before diagnosing clozapine-refractory illness. Only after therapeutic clozapine levels are confirmed as ineffective should augmentation with electroconvulsive therapy (ECT) or a secondary agent be utilized.

Adım Adım Çözüm

1
Identify the appropriate initial treatment for a first-episode of psychosis.
Prescribe an oral second-generation antipsychotic.
Oral SGAs are first-line therapy due to their efficacy and lower risk of extrapyramidal symptoms compared to first-generation agents.
2
Determine the next step after a relapse precipitated by medication nonadherence.
Transition to a long-acting injectable (LAI) antipsychotic.
LAIs eliminate covert nonadherence, ensuring reliable drug delivery to prevent further relapses and establish true medication efficacy.
3
Identify the management for persistent symptoms despite assured delivery of prior antipsychotic trials.
Initiate clozapine therapy with ANC monitoring.
Failure of at least two adequate antipsychotic trials (including one that guarantees adherence via LAI) defines treatment-resistant schizophrenia, for which clozapine is the gold standard.
4
Determine the correct action when standard doses of clozapine fail to produce an adequate clinical response.
Check a clozapine serum level.
Before declaring a patient clozapine-refractory, serum levels must be obtained to rule out rapid metabolism, drug interactions, or other pharmacokinetic causes of treatment failure.
5
Identify the ultimate step for definitive clozapine-refractory schizophrenia.
Augment the regimen with electroconvulsive therapy (ECT).
When a patient fails to respond despite confirmed therapeutic clozapine serum levels, augmentation with ECT or a secondary antipsychotic agent is the appropriate next step.

Anahtar Kavram

The stepwise management algorithm for schizophrenia from initial diagnosis to definitively treatment-refractory illness.
Bu soruyu puanla